Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Chabot

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|April 8, 2003
A pharmacy-based health promotion programme in hypertension: cost-benefit analysisIsabelle Côté, Jean-Pierre Grégoire, Jocelyne Moisan, et al.
The International Journal of Neuroscience|October 20, 2021
Understanding the unmet needs in insomnia treatment: a systematic literature review of real-world evidenceRenee Campbell, Isabelle Chabot, Ben Rousseau, et al.
BMC Health Services Research|March 16, 2006
Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental studyJean-Pierre Grégoire, Jocelyne Moisan, Louise Potvin, et al.
Future Oncology (London, England)|June 11, 2024
Disease landscape of advanced HER2-breast cancer patients by treatment line in three EU countries and USAKerigo Ndirangu, Isabelle Chabot, Katie Lewis, et al.
The Canadian Journal of Cardiology|May 21, 2004
Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspectiveEllen D Burgess, George W Carides, William C Gerth, et al.
BMC Cancer|July 1, 2021
Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancerQi Zhao, Rachel Hughes, Binod Neupane, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 1, 2022
Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacyAlexandre Marineau, Catherine St-Pierre, Roxanne Lessard-Hurtubise, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|October 17, 2021
A Pre-Phase III Efficacy Trial of the Spermicide/Contraceptive Effect of the Invisible Condom, a Non-Hormonal Vaginal Gel, in Women from CanadaRabeea F Omar, Mathieu Leboeuf, Madeleine Lemyre, et al.
Exploratory Research in Clinical and Social Pharmacy|September 2, 2022
Development of a community pharmacy-based intervention for patients with uncontrolled asthmaClaudie Turcotte, Rébecca Fénélon-Dimanche, Catherine Lemière, et al.
Journal of Patient-Reported Outcomes|July 1, 2024
Re-examining the factor structure of the Insomnia Severity Index (ISI) and defining the meaningful within-individual change (MWIC) for subjects with insomnia disorder in two phase III clinical trials of the efficacy of lemborexantWilliam R Lenderking, Yulia Savva, Mark J Atkinson, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|April 8, 2003
A pharmacy-based health promotion programme in hypertension: cost-benefit analysisIsabelle Côté, Jean-Pierre Grégoire, Jocelyne Moisan, et al.
The International Journal of Neuroscience|October 20, 2021
Understanding the unmet needs in insomnia treatment: a systematic literature review of real-world evidenceRenee Campbell, Isabelle Chabot, Ben Rousseau, et al.
BMC Health Services Research|March 16, 2006
Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental studyJean-Pierre Grégoire, Jocelyne Moisan, Louise Potvin, et al.
Future Oncology (London, England)|June 11, 2024
Disease landscape of advanced HER2-breast cancer patients by treatment line in three EU countries and USAKerigo Ndirangu, Isabelle Chabot, Katie Lewis, et al.
The Canadian Journal of Cardiology|May 21, 2004
Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspectiveEllen D Burgess, George W Carides, William C Gerth, et al.
BMC Cancer|July 1, 2021
Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancerQi Zhao, Rachel Hughes, Binod Neupane, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 1, 2022
Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacyAlexandre Marineau, Catherine St-Pierre, Roxanne Lessard-Hurtubise, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|October 17, 2021
A Pre-Phase III Efficacy Trial of the Spermicide/Contraceptive Effect of the Invisible Condom, a Non-Hormonal Vaginal Gel, in Women from CanadaRabeea F Omar, Mathieu Leboeuf, Madeleine Lemyre, et al.
Exploratory Research in Clinical and Social Pharmacy|September 2, 2022
Development of a community pharmacy-based intervention for patients with uncontrolled asthmaClaudie Turcotte, Rébecca Fénélon-Dimanche, Catherine Lemière, et al.
Journal of Patient-Reported Outcomes|July 1, 2024
Re-examining the factor structure of the Insomnia Severity Index (ISI) and defining the meaningful within-individual change (MWIC) for subjects with insomnia disorder in two phase III clinical trials of the efficacy of lemborexantWilliam R Lenderking, Yulia Savva, Mark J Atkinson, et al.
Pageof 3